- |||||||||| INCB47986 / Incyte
Enrollment change, Trial termination, Trial primary completion date: INCB047986 in Rheumatoid Arthritis (clinicaltrials.gov) - Feb 23, 2015
P2, N=3, Terminated,
N=60 --> 3 | Recruiting --> Terminated | Trial primary completion date: May 2015 --> Aug 2014; Business decision.
- |||||||||| INCB47986 / Incyte
Enrollment change, Trial termination, Trial primary completion date: Randomized Open-Label Study of INCB047986 in Subjects With Primary Myelodysplastic Syndrome (MDS) (clinicaltrials.gov) - Feb 23, 2015
P1/2, N=6, Terminated,
N=60 --> 3 | Recruiting --> Terminated | Trial primary completion date: May 2015 --> Aug 2014; Business decision. N=100 --> 6 | Active, not recruiting --> Terminated | Trial primary completion date: Aug 2016 --> Sep 2014; Business decision.
- |||||||||| INCB47986 / Incyte
Enrollment change, Trial termination, IO biomarker, Metastases: An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies (clinicaltrials.gov) - Feb 5, 2015
P1, N=5, Terminated,
N=100 --> 6 | Active, not recruiting --> Terminated | Trial primary completion date: Aug 2016 --> Sep 2014; Business decision. N=100 --> 5 | Active, not recruiting --> Terminated; Business decision.
- |||||||||| INCB47986 / Incyte
Enrollment closed, Enrollment change, Trial primary completion date, IO biomarker, Metastases: An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies (clinicaltrials.gov) - Aug 15, 2014
P1, N=100, Active, not recruiting,
Recruiting --> Active, not recruiting Not yet recruiting --> Active, not recruiting | N=60 --> 100 | Trial primary completion date: Oct 2015 --> Oct 2014
- |||||||||| INCB47986 / Incyte
Enrollment open: INCB047986 in Rheumatoid Arthritis (clinicaltrials.gov) - May 27, 2014
P2, N=60, Recruiting,
Not yet recruiting --> Active, not recruiting | N=60 --> 100 | Trial primary completion date: Oct 2015 --> Oct 2014 Not yet recruiting --> Recruiting
|
